Structural basis for the inhibition ofMycobacterium tuberculosisL,D-transpeptidase by meropenem, a drug effective against extensively drug-resistant strains
about
Peptidoglycan remodeling by the coordinated action of multispecific enzymesStructures of free and inhibited forms of the L,D-transpeptidase LdtMt1 from Mycobacterium tuberculosisKinetic features of L,D-transpeptidase inactivation critical for β-lactam antibacterial activityThe Cell Shape-determining Csd6 Protein from Helicobacter pylori Constitutes a New Family of L,D-Carboxypeptidase.Binding and processing of β-lactam antibiotics by the transpeptidase LdtMt2 from Mycobacterium tuberculosis.Structural insight into the inactivation of Mycobacterium tuberculosis non-classical transpeptidase LdtMt2 by biapenem and tebipenem.Non-classical transpeptidases yield insight into new antibacterialsGenetic characterization of mycobacterial L,D-transpeptidases.Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus.Loss of a Functionally and Structurally Distinct ld-Transpeptidase, LdtMt5, Compromises Cell Wall Integrity in Mycobacterium tuberculosis.Acyl acceptor recognition by Enterococcus faecium L,D-transpeptidase Ldtfm.Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosisl,d-transpeptidase 2Nonclassical transpeptidases of Mycobacterium tuberculosis alter cell size, morphology, the cytosolic matrix, protein localization, virulence, and resistance to β-lactamsThe Mycobacterial Cell Wall--Peptidoglycan and Arabinogalactan.LdtMav2, a nonclassical transpeptidase and susceptibility of Mycobacterium avium to carbapenems.Differential flap dynamics in l,d-transpeptidase2 from mycobacterium tuberculosis revealed by molecular dynamics.Simulating the inhibition reaction of Mycobacterium tuberculosis L,D-transpeptidase 2 by carbapenems.Interaction of meropenem with 'N' and 'B' isoforms of human serum albumin: a spectroscopic and molecular docking study.Targeting the cell wall of Mycobacterium tuberculosis: a molecular modeling investigation of the interaction of imipenem and meropenem with L,D-transpeptidase 2.Atomic model of a cell-wall cross-linking enzyme in complex with an intact bacterial peptidoglycan.Building a Full-Atom Model of L,Dtranspeptidase 2 from Mycobacterium tuberculosis for Screening New Inhibitors.Reaction Mechanism of Mycobacterium Tuberculosis Glutamine Synthetase Using Quantum Mechanics/Molecular Mechanics Calculations.Mycobacterium abscessus l,d-Transpeptidases Are Susceptible to Inactivation by Carbapenems and Cephalosporins but Not Penicillins.and β-Lactams: Emerging Insights and Potential OpportunitiesMycobacterial Cell Wall Synthesis Inhibitors Cause Lethal ATP Burst
P2860
Q27011518-60F218D2-1E6C-4B7B-8FF2-EE767538E05BQ27685445-2CD725E3-074C-4D1E-8594-60F2C3961C09Q28534519-07EFBC46-FE82-4C71-B7BD-FF1BB1FDCA81Q30378358-CEF3875F-E3A0-4412-89B5-45CE7512C0FAQ30397294-B7DCA835-3F7A-4200-8E48-150CF4628069Q33730985-F29C0490-CAA6-4597-97BE-CAFAFF01A6BCQ33814192-FBD1FF08-EA01-4D92-8811-0498DABA6F8AQ33980489-D3899D1C-8362-4FC0-A2F9-71D74568A625Q36075809-FB020311-8840-47E1-A4B4-B3124D8C74A1Q36283392-4D020B3E-0B8C-4A06-BC91-AE466C8E1614Q36405931-D03DF8CE-31A5-43DF-B5D4-98458F044A77Q36697086-5021577D-1D91-474E-BADD-8C18B19245A9Q37713160-741B43D1-8F99-4FEC-916A-10C99448F13DQ38394431-68240B8D-C69A-4B0F-A1C4-40D97DDF0271Q38677546-BDD63AF3-DEE3-4493-B1D5-3EE820BE7E44Q40222330-4733D9E6-EAE1-460E-97E1-85F1C494C1D6Q40759526-1040D738-6C1A-4B26-AA4E-ADEEA0E46936Q41357879-BF832731-153F-4721-AA0D-C9012B72D85CQ41437092-024ACC69-0869-4DF5-BDF8-525853A95A43Q41833395-2A15EE25-3FD9-4F22-A81F-F9BE35DCE7CBQ41868857-8FC49AFA-4CC0-4153-8796-D1F7E119183DQ48042543-C02FBC8F-46B4-4AA1-98B2-1E8655B67D7DQ48318081-F1A85676-8CC5-4DC5-86E1-A7014AC3BA42Q57492057-0C31FA25-EA16-4701-A916-75728F18C7A0Q58777351-359F0076-03F9-4D88-B44E-2B81CFBC5AA2
P2860
Structural basis for the inhibition ofMycobacterium tuberculosisL,D-transpeptidase by meropenem, a drug effective against extensively drug-resistant strains
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Structural basis for the inhib ...... nsively drug-resistant strains
@ast
Structural basis for the inhib ...... nsively drug-resistant strains
@en
Structural basis for the inhib ...... nsively drug-resistant strains
@nl
type
label
Structural basis for the inhib ...... nsively drug-resistant strains
@ast
Structural basis for the inhib ...... nsively drug-resistant strains
@en
Structural basis for the inhib ...... nsively drug-resistant strains
@nl
prefLabel
Structural basis for the inhib ...... nsively drug-resistant strains
@ast
Structural basis for the inhib ...... nsively drug-resistant strains
@en
Structural basis for the inhib ...... nsively drug-resistant strains
@nl
P2093
P2860
P1476
Structural basis for the inhib ...... nsively drug-resistant strains
@en
P2093
Byung Woo Han
Hye Jin Yoon
Hye Kyeoung Min
Hyoun Sook Kim
Jae Young Lee
Ji Young Yoon
Jin Young Kim
P2860
P304
P356
10.1107/S0907444912048998
P577
2013-03-01T00:00:00Z